Evidence map›Paper›PMID 35612505›Full record

ArticleActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale2022

Oral tongue carcinoma: prognostic changes according to the updated 2020 version of the AJCC/UICC TNM staging system.

Marta Tagliabue, Rita De Berardinis, Pietro Belloni, Sara Gandini, Donatella Scaglione, Fausto Maffini, Rosolino Antonino Mirabella, Stefano Riccio, Giugliano Gioacchino, Roberto Bruschini and 2 more

Open access · goldAbstract read
In one paragraph

Article in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Marta TagliabueDivision of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Rita De BerardinisDivision of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Pietro BelloniDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Sara GandiniDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Donatella ScaglioneDivision of Data Management, European Institute of Oncology IRCCS, Milan, Italy.
Fausto MaffiniDivision of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Rosolino Antonino MirabellaDepartment of Otorhinolaryngology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Stefano RiccioDivision of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Giugliano GioacchinoDivision of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Roberto BruschiniDivision of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Francesco ChuDivision of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Mohssen AnsarinDivision of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy.
European Institute of Oncology · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Sassari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study aimed to evaluate the performance of the 2017 8 Materials and methods: The cohort involved 300 patients affected by OTSCC treated with surgery. All cases were classified according to the 7 Results: According to the 7 Conclusions: This study confirmed that the recent update of the 8th edition of the TNM (2020) improves stratification and identification of advanced tumours, reducing the number of T3 compared to the 2017 edition and increasing the number of patients with pT4. This improvement made by the updated edition may reduce the risk of skipping adjuvant therapy.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsMouth NeoplasmsTongue NeoplasmsHumansNeoplasm Recurrence, LocalNeoplasm StagingPrognosisRetrospective StudiesSquamous Cell Carcinoma of Head and NeckTonguedepth of invasion (DOI)prognosisstage migrationsurvivalTNMtongue cancer

Identifiers

PMID35612505
PMCPMC9131996
OpenAlexW4281383572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.